English
RPG Life Sciences Q4 Results
- BSE: 532983
- NSE: RPGLIFE
- ISIN: INE105J01010
- Sector: Biotechnology & Drugs
BSE
2,228.80
28.05 (1.27%)
28.05 (1.27%)Volume64.00
Updated: Fri 5 Dec, 2025 | 15:29:10
NSE
2,198.00
-10.30 (-0.47%)
-10.30 (-0.47%)Volume4.55 K
Updated: Fri 5 Dec, 2025 | 15:29:56
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - RPG Life Sciences Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 13.07 | 129.01 | -89.87% | 110.76 | -88.20% |
| Depreciation/ Amortization | 5.37 | 5.46 | -1.65% | 4.49 | 19.60% |
| Operating Income | 130.02 | 43.70 | 197.53% | 16.23 | 701.11% |
| Net Income | 117.35 | 34.93 | 235.96% | 13.24 | 786.33% |
| Other Operating Expenses Total | 37.28 | 38.73 | -3.74% | 30.05 | 24.06% |
| Net Income Before Taxes | 134.90 | 46.89 | 187.69% | 17.74 | 660.43% |
| Total Revenue | 143.09 | 172.71 | -17.15% | 126.99 | 12.68% |
| Selling/ General/ Admin Expenses Total | 31.60 | 28.71 | 10.07% | 34.78 | -9.14% |
| Diluted Normalized EPS | 13.15 | 21.12 | -37.74% | 8.00 | 64.38% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.